The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
MAPK cascade signalling and synaptic plasticity
Thomas, G. M., & Huganir, R. L. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1346 · Cited by 1,454
Ahlskog, J. E., & Muenter, M. D. (2001) · Movement Disorders · doi:10.1002/mds.1090 · Cited by 1,454
Sleep and arousal: thalamocortical mechanisms
McCormick, D. A., & Bal, T. (1997) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.20.1.185 · Cited by 1,267
Deep brain stimulation for Parkinson’s disease
Benabid, A. L. (2003) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2003.11.001 · Cited by 1,046
Schultz, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.007 · Cited by 1,028
Description of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977
Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens
Nicola, S. M., Surmeier, D. J., & Malenka, R. C. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.185 · Cited by 931
Dopamine-mediated regulation of corticostriatal synaptic plasticity
Calabresi, P., Picconi, B., Tozzi, A., & Di Filippo, M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.001 · Cited by 865
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821
Self-citationDay, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745
A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus
Plenz, D., & Kital, S. T. (1999) · Nature · doi:10.1038/23281 · Cited by 712
Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664
Self-citationThe basal ganglia: learning new tricks and loving it
Graybiel, A. M. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.10.006 · Cited by 649
Cenci, M. A., Lee, C. S., & Björklund, A. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00285.x · Cited by 641
Self-citationMove to the rhythm: oscillations in the subthalamic nucleus–external globus pallidus network
Bevan, M. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02235-x · Cited by 638
Dyskinesias and motor fluctuations in Parkinson's disease
Schrag, A., & Quinn, N. (2000) · Brain · doi:10.1093/brain/123.11.2297 · Cited by 600
Caffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3269-3 · Cited by 538
Basal ganglia local field potential activity: Character and functional significance in the human
Brown, P., & Williams, D. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.05.009 · Cited by 526
E PIDEMIOLOGY OF N EURODEGENERATION
Mayeux, R. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.043002.094919 · Cited by 515
Winkler, C., Kirik, D., Björklund, A., & Cenci, M. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0499 · Cited by 430
Self-citationMallet, N., Ballion, B., Le Moine, C., & Gonon, F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4439-05.2006 · Cited by 413
de la Fuente-Fernandez, R. (2004) · Brain · doi:10.1093/brain/awh290 · Cited by 402
Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
Aubert, I., Guigoni, C., Håkansson, K., Li, Q., Dovero, S., Barthe, N., Bioulac, B. H., Gross, C. E., Fisone, G., Bloch, B., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20296 · Cited by 387
DAncing past the DAT at a DA synapse
Cragg, S. J., & Rice, M. E. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.03.011 · Cited by 374
Gerfen, C. R., Miyachi, S., Paletzki, R., & Brown, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05042.2002 · Cited by 373
An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1996) · Brain · doi:10.1093/brain/119.2.585 · Cited by 366
Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease
Alonso-Frech, F. (2006) · Brain · doi:10.1093/brain/awl103 · Cited by 358
Levodopa‐induced dyskinesia: Review, observations, and speculations
Nutt, M. (1990) · Neurology · doi:10.1212/wnl.40.2.340 · Cited by 358
Andersson, M., Hilbertson, A., & Cenci, M. A. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0259 · Cited by 350
Self-citationCompetition between Feedback Loops Underlies Normal and Pathological Dynamics in the Basal Ganglia
Leblois, A., Boraud, T., Meissner, W., Bergman, H., & Hansel, D. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5050-05.2006 · Cited by 349
Effects ofl-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats
Abercrombie, E. D., Bonatz, A. E., & Zigmond, M. J. (1990) · Brain Research · doi:10.1016/0006-8993(90)91318-b · Cited by 332
Venton, B. J., Zhang, H., Garris, P. A., Phillips, P. E. M., Sulzer, D., & Wightman, R. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02109.x · Cited by 283
Westin, J. E., Vercammen, L., Strome, E. M., Konradi, C., & Cenci, M. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.032 · Cited by 277
Self-citationLei, W., Jiao, Y., Del Mar, N., & Reiner, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1990-04.2004 · Cited by 277
Reiner, A., & Anderson, K. D. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90003-7 · Cited by 272
Lévesque, M., & Parent, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502710102 · Cited by 222
Post‐ versus presynaptic plasticity in L‐DOPA‐induced dyskinesia
Cenci, M. A., & Lundblad, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04124.x · Cited by 218
Self-citationMela, F., Marti, M., Dekundy, A., Danysz, W., Morari, M., & Cenci, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04456.x · Cited by 205
Self-citationNondopaminergic mechanisms in levodopa‐induced dyskinesia
Brotchie, J. M. (2005) · Movement Disorders · doi:10.1002/mds.20612 · Cited by 192
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: A PET study
Pavese, N., Evans, A. H., Tai, Y. F., Hotton, G., Brooks, D. J., Lees, A. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000242888.30755.5d · Cited by 191
Levodopa therapy: Consequences of the nonphysiologic replacement of dopamine
Chase, T. N. (1998) · Neurology · doi:10.1212/wnl.50.5_suppl_5.s17 · Cited by 180
Magill, P. J., Sharott, A., Bevan, M. D., Brown, P., & Bolam, J. P. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00134.2004 · Cited by 164
Cortical motor overactivation in parkinsonian patients with L-dopa- induced peak-dose dyskinesia
Rascol, O. (1998) · Brain · doi:10.1093/brain/121.3.527 · Cited by 164
Development of dyskinesias in a 5‐year trial of ropinirole and L ‐dopa
Rascol, O., Brooks, D. J., Korczyn, A. D., Deyn, P. P. D., Clarke, C. E., Lang, A. E., & Abdalla, M. (2006) · Movement Disorders · doi:10.1002/mds.20988 · Cited by 161
Atherton, J. F., & Bevan, M. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1475-05.2005 · Cited by 161
Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia
Konradi, C., Westin, J. E., Carta, M., Eaton, M. E., Kuter, K., Dekundy, A., Lundblad, M., & Cenci, M. A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.005 · Cited by 159
Self-citationBlanchet, P. J., Konitsiotis, S., Whittemore, E. R., Zhou, Z. L., Woodward, R. M., & Chase, T. N. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35003-7 · Cited by 158
Role of striatal l ‐DOPA in the production of dyskinesia in 6‐hydroxydopamine lesioned rats
Carta, M., Lindgren, H. S., Lundblad, M., Stancampiano, R., Fadda, F., & Cenci, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03696.x · Cited by 157
Self-citationMeissner, W. G., Ravenscroft, P., Reese, R., Harnack, D., Morgenstern, R., Kupsch, A. R., Klitgaard, H., Bioulac, B. H., Gross, C. E., Bézard, E., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.009 · Cited by 150
A 2-DEOXYGLUCOSE STUDY OF THE EFFECTS OF DOPAMINE AGONISTS ON THE PARKINSONIAN PRIMATE BRAIN
Mitchell, I., Boyce, S., Sambrook, M. A., & Crossman, A. R. (1992) · Brain · doi:10.1093/brain/115.3.809 · Cited by 128
Clinical–Pathological study of levodopa complications
Rajput, A. H., Fenton, M. E., Birdi, S., Macaulay, R. J. B., George, D. H., Rozdilsky, B., Ang, L. C., Senthilselvan, A., & Hornykiewicz, O. (2002) · Movement Disorders · doi:10.1002/mds.10031 · Cited by 127
Lindgren, H. S., Ottosson, D. R., Ohlin, K. E., Lundblad, M., & Cenci, M. A. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.09.019 · Cited by 111
Self-citationCalon, F., Morissette, M., Rajput, A. H., Hornykiewicz, O., Bédard, P. J., & Paolo, T. D. (2002) · Movement Disorders · doi:10.1002/mds.10343 · Cited by 110
Sgambato, V., Buggia-Prévot, V., Gilbert, F., Lévesque, D., Benabid, A. L., & Berger, F. R. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000186922.42592.b7 · Cited by 108
Fox, S. H., Lang, A. E., & Brotchie, J. M. (2006) · Movement Disorders · doi:10.1002/mds.20936 · Cited by 105
Nadjar, A., Brotchie, J. M., Guigoni, C., Li, Q., Zhou, S., Wang, G.-J., Ravenscroft, P., Georges, F. E., Crossman, A. R., & Bézard, E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2582-06.2006 · Cited by 98
Nash, J. E., Ravenscroft, P., McGuire, S., Crossman, A. R., Menniti, F. S., & Brotchie, J. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.004 · Cited by 94
Hallworth, N. E., & Bevan, M. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0450-05.2005 · Cited by 92
Liu, X., Ford-Dunn, H. L., Hayward, G., Nandi, D., Miall, R. C., Aziz, T. Z., & Stein, J. F. (2002) · Clinical Neurophysiology · doi:10.1016/s1388-2457(02)00256-0 · Cited by 92
Lane, E. L., Winkler, C., Brundin, P., & Cenci, M. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.011 · Cited by 90
Self-citationCarlsson, T. (2005) · Brain · doi:10.1093/brain/awh374 · Cited by 88
Aubert, I., Guigoni, C., Li, Q., Doveró, S., Bioulac, B. H., Gross, C. E., Crossman, A. R., Bloch, B., & Bézard, E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.038 · Cited by 85
Guigoni, C., Doveró, S., Aubert, I., Li, Q., Bioulac, B. H., Bloch, B., Gurevich, E. V., Gross, C. E., & Bézard, E. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04196.x · Cited by 82
Factors influencing the onset and persistence of dyskinesia in MPTP-treated primates.
Jenner, P. G. (2000) · PubMed · Cited by 77
Carta, A. R., Tronci, E., Pinna, A., & Morelli, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03944.x · Cited by 70
Levodopa Infusion Therapy in Parkinson Disease: State of the Art in 2004
Nyholm, D., & Aquilonius, S. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000144041.28224.b7 · Cited by 66
D1receptor blockade improves l -dopa–induced dyskinesia but worsens parkinsonism in MPTP monkeys
Grondin, R., Doan, V. D., Grégoire, L., & Bédard, P. J. (1999) · Neurology · doi:10.1212/wnl.52.4.771 · Cited by 63
St‐Hilaire, M., Landry, E. S., Lévesque, D., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.001 · Cited by 54
Windels, F., & Kiyatkin, E. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1528-04.2004 · Cited by 53
Mazzella, L., Yahr, M. D., Marinelli, L., Huang, N., Moshier, E. L., & Rocco, A. D. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.002 · Cited by 30
Cited by
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Metabotropic glutamate receptors: From the workbench to the bedside
Nicoletti, F., Bockaert, J., Collingridge, G. L., Conn, P. J., Ferraguti, F., Schoepp, D. D., Wroblewski, J. T., & Pin, J. P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.022 · Cited by 653
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Novelty and Dopaminergic Modulation of Memory Persistence: A Tale of Two Systems
Duszkiewicz, A. J., McNamara, C. G., Takeuchi, T., & Genzel, L. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.10.002 · Cited by 301
Fieblinger, T., Graves, S. M., Sebel, L. E., Alcacer, C., Plotkin, J. L., Gertler, T. S., Chan, C. S., Heiman, M., Greengard, P., Cenci, M. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6316 · Cited by 295
Self-citation
Metadata
- Authors
- Cenci, M. A.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 30
- Issue
- 5
- Pages
- 236-243
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2103095851
- Cited by
- 265
- References
- 72
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.